Événements S-GE Country Event: Opportunités de business en Inde 22 mai 2024 16:15–18:20 Lugano Suisse
News 26 oct 2022 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...
News 26 mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon 23 avr 2024 10:15–12:10 Zürich Suisse
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan 23 avr 2024 10:15–12:10 Zürich Suisse
News 25 oct 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News 04 oct 2023 Atinary Technologies raises USD 5 million to accelerate material and molecular innovation Vaud-based machine learning specialist Atinary Technologies has raised USD 5 million, propelling the start-up towards a new era of material and m...
News 10 déc 2021 Synpulse and Thought Machine collaborating Global corporate consulting firm Synpulse has entered into partnership with fintech unicorn Thought Machine from the UK. In this collaboration, S...
News 01 nov 2023 Bacthera’s Visp plant aims to revolutionize microbiome-based treatments In Visp, Bacthera’s MC4a Center of Excellence readies to manufacture transformative microbiome therapies, notably the Seres Therapteutics’ life-s...
Aktuell 10 déc 2021 Synpulse und Thought Machine kollaborieren Die global tätige Unternehmensberatung Synpulse hat eine Partnerschaft mit dem britischen Fintech-Einhorn Thought Machine geschlossen. Dabei agie...
News 14 aoû 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
News 30 sep 2021 Basel Area becomes the Swiss hotspot for Chinese pharma companies More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them is Hengrui...
Aktuell 30 sep 2021 Basel Area wird zum Schweizer Hotspot für chinesische Pharmafirmen Immer mehr chinesische Pharmaunternehmen wählen die Basel Area als Standort für ihre Niederlassung in der Schweiz. Unter ihnen ist Hengrui Medici...